Medical Cannabis/Marijuana Industry Analysis Report- By Cannabis Strains(Indica (High CBD), Sativa (High THC)), By Implications( Anxiety, Epilepsy, Cancer, Chronic Pain, Dermatology), & By Geography

Medical Cannabis Market in the Global Industry Landscape

Cannabis is increasingly expanding its foothold in healthcare industry over the past few years. Cannabis is illegal to consume if otherwise used in approved pharmaceuticals legalized by the country. Till now (2017), only Australia, Canada, Israel, U.S and Europe have medicinal cannabis market.  Australia legalized the use of medical cannabis in 2016, and initial demands were encountered through the imports. Various jurisdictions have either illegalized the cannabis or have legalized cannabis for medical purposes. But the growing acceptance of cannabis all over the world, some have even legalized cannabis for recreational purpose. The companies in the industry have different target areas, some are targeting nutraceuticals and based on the therapeutical benefits are developing products; and some companies are manufacturing range of drugs based on cannabis targeting multiple diseases such as cancer, epilepsy and chronic pain.

The patients with acute diseases have increasing demand for cannabis medicines as they are becoming aware of its benefits. Cannabis is also gaining attention from the pharmaceutical & biotechnology research & development segment of healthcare industry & the drug approval authorities. Medical cannabis have cannabinoids that interacts with the Endocannabinoid System in human body, which impacts nearly all pathological conditions - cardiovascular, reproductive, gastrointestinal, neurodegenerative, liver, psychiatric, lunch skeletal, and cancer diseases. The patients with acute diseases have increasing demand for cannabis medicines as they are becoming aware of its benefits.

Our Global Medical Cannabis Market can be segmented on the following basis:

Based on Cannabis Strains

• Indica (High CBD)
• Sativa (High THC)

Based on Implications

• Anxiety
• Epilepsy
• Cancer
• Chronic Pain
• Dermatology
• Others

Based on Geography

• North America (U.S. & Canada)  Medical cannabis  Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Argentina, Uruguay, Chile, Colombia, Peru and Mexico)  Medical cannabis  Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Netherlands, Russia, Spain, Switzerland and Austria)  Medical cannabis  Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (Australia, Bangladesh)  Medical cannabis  Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (Israel) Medical cannabis  Market {Market Share (%), Market Size (USD Billion)}

In 2017 on the basis of implications, medical cannabis for chronic pain accounted for largest market share in the global medical cannabis market followed by cancer treatment. Cannabis has proved to be useful for patients suffering from chronic pain & neuropathic pain. Moreover continuous research & development & clinical trials is witnessed related to the medicines for pain management. In near future, application of medical cannabis in pain management segment will acquire largest market share.

U.S. Medical Cannabis Application Scenario:-

US have legalized cannabis for both medical & recreational activities in various states. Medical cannabis is one of the fastest growing segment in the healthcare industry, and its usage is expanding to multiple states every year & by the end of 2017 medical cannabis is legalized in 30 states as compared to 8 states legalized for recreational cannabis. Although chronic pain is the largest segment for application of medical cannabis, but only few percent of people are using cannabis. Further, in terms of cannabis business opportunities in the U.S., the companies have profitable opportunities Arizona, Nevada & Massachusetts. The market also provides attractive price expansion opportunities & well capitalization facility.

Global medical cannabis market report includes:

• Medical cannabis market size (USD) and market compounded annual growth rate (%), 2017-2025.
• Medical cannabis retail sales (USD), 2017-2025.
• Medical cannabis medicines approval scenario, 2017-18.
• Number of registered patients active on medical marijuana, by age & disease, 2017-18.
• Countries having approved medical cannabis, 2017-18.
• Medical cannabis market drivers, challenges & opportunities.
• Mergers & acquisition activities, and key players competition analysis.

Key questions answered in this Global Marijuana Industry Analysis Report

• What is the total market size by 2025 and what would be the expected growth rate of market?
• What is the total revenue per segment and region in 2015-16 and what would be the expected revenue per segment and region over the forecast period?
• What are the key market trends and recent advancement in the industry?
• What are the factors which are driving this market?
• What are the major factors that restraints market growth?
• Who are the key vendors in this medical cannabis market space?
• What are the market opportunities for the existing and new entry level players?
• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for medical cannabis industry
• Develop strategies based on the latest regulatory framework
• Position yourself to gain the maximum advantage of the medical marijuana market’s growth potential
• Identify key partners and business development avenues across the globe
• Respond to your competitors’ business structure, strategy and prospects